The options have an exercise price of
About
Contact:
Investor
T: +1 919 859 7910
E: jbluth@biocryst.com
Media
Catherine Collier Kyroulis
T: +1 917 886 5586
E: ckyroulis@biocryst.com
(C) 2022 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.345 USD | -3.74% | +13.25% | +22.70% |
07-09 | BioCryst Pharmaceuticals Says Orladeyo Approved in Peru | MT |
07-03 | Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule | MT |
The options have an exercise price of
About
Contact:
Investor
T: +1 919 859 7910
E: jbluth@biocryst.com
Media
Catherine Collier Kyroulis
T: +1 917 886 5586
E: ckyroulis@biocryst.com
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+22.70% | 1.57B | |
+19.43% | 126B | |
+22.71% | 118B | |
+23.26% | 27.87B | |
-19.33% | 20.95B | |
-15.13% | 16.92B | |
-14.64% | 16.18B | |
+9.49% | 14.84B | |
-46.10% | 14.79B | |
+50.48% | 14.08B |